Imran Talat 4
4 · Rani Therapeutics Holdings, Inc. · Filed Jul 21, 2026
Research Summary
AI-generated summary of this filing
Rani Therapeutics (RANI) CEO Imran Talat Sells Shares
What Happened
Imran Talat, CEO of Rani Therapeutics (RANI), reported a series of share dispositions (sales/withholdings) between 2024-12-27 and 2026-06-27 totaling about $55,028. Transactions include an open-market sale of 8,014 shares on 2024-12-27 at $1.41 ($11,300) and multiple dispositions listed as "F" (payment of exercise price or tax liability) involving 9,076; 9,077; 7,906; 8,916; 9,099; and 7,927 shares at prices from $0.48 to $1.40 (individual values shown in the filing). Most of these F-coded transactions represent shares withheld or sold to satisfy tax withholding obligations tied to the settlement/release of restricted stock units (RSUs).
Key Details
- Transaction dates and proceeds (selected):
- 2024-12-27: 8,014 shares @ $1.41 = $11,300 (open market sale)
- 2025-06-27: 9,076 shares @ $0.55 = $4,992 (tax withholding)
- 2025-09-27: 9,077 shares @ $0.48 = $4,357 (tax withholding)
- 2025-12-27: 7,906 shares @ $1.40 = $11,068 (tax withholding)
- 2026-03-22: 8,916 shares @ $1.13 = $10,075 (tax withholding)
- 2026-03-27: 9,099 shares @ $0.81 = $7,370 (tax withholding)
- 2026-06-27: 7,927 shares @ $0.74 = $5,866 (tax withholding)
- Total proceeds across listed dispositions: ≈ $55,028.
- Shares owned after the reported transactions are not specified in the provided summary; the filing notes 12,343 shares are held by VH Moll, L.P., in which the reporting person disclaims beneficial ownership except for any pecuniary interest.
- Footnotes: F2/F4 indicate sales or withholding to satisfy tax obligations related to RSU settlements; F1 notes a late report due to inadvertent administrative oversight; F3 is the VH Moll LP disclosure.
- Timeliness: Filing was reported late (footnote F1), which delays disclosure but does not itself indicate wrongdoing.
Context
Most transactions are tax-withholding dispositions tied to the settlement/release of RSUs (a common, routine event when restricted shares vest). That makes these sales largely administrative (to satisfy tax liabilities) rather than an obvious market-timing sell signal. The single open-market sale on 2024-12-27 is a conventional sale; together with the withholding actions, these types of filings commonly reflect compensation-related disposals rather than new investment decisions.
Insider Transaction Report
- Sale
Class A Common Stock
[F1][F2][F3]2024-12-27$1.41/sh−8,014$11,300→ 486,737 total - Tax Payment
Class A Common Stock
[F1][F4][F3]2025-06-27$0.55/sh−9,076$4,992→ 477,661 total - Tax Payment
Class A Common Stock
[F1][F4][F3]2025-09-27$0.48/sh−9,077$4,357→ 468,584 total - Tax Payment
Class A Common Stock
[F1][F4][F3]2025-12-27$1.40/sh−7,906$11,068→ 460,678 total - Tax Payment
Class A Common Stock
[F1][F4][F3]2026-03-22$1.13/sh−8,916$10,075→ 451,762 total - Tax Payment
Class A Common Stock
[F1][F4][F3]2026-03-27$0.81/sh−9,099$7,370→ 442,663 total - Tax Payment
Class A Common Stock
[F1][F4][F3]2026-06-27$0.74/sh−7,927$5,866→ 434,736 total
Footnotes (4)
- [F1]This transaction is being reported late due to inadvertent administrative oversight.
- [F2]Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of the restricted stock units.
- [F3]Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units.